SCHEMBL22459387

SCHEMBL22459387

C=C(C)C(=O)OCCCc1ccc(-c2ccc(OCCOC(=O)C(=C)COC)cc2OC)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.40
▸ APEX1 P27695 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ PPARG P37231 4/20 0.36
▸ TNKS2 Q9H2K2 1/20 0.36
▸ CYP11B1 P15538 2/20 0.35
▸ CYP11B2 P19099 2/20 0.35
▸ MAPK1 P28482 3/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ MAPT P10636 2/20 0.35
▸ HSD17B10 Q99714 2/20 0.35
▸ NAAA Q02083 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ PPARD Q03181 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22459568 0.96 PPARG (0.39) PPARGTNKS2CYP11B1CYP11B2MAPK1
SCHEMBL22459247 0.92 POLB (0.42) POLBAPEX1HTTTDP1CYP11B1
SCHEMBL22459240 0.91 TNKS2 (0.41) POLBAPEX1HTTTDP1PPARG
SCHEMBL22459694 0.90 MET (0.38) PPARGCYP11B1CYP11B2MAPTNAAA
SCHEMBL22459342 0.90 POLB (0.41) POLBAPEX1HTTTDP1PPARG
SCHEMBL22459385 0.89 POLB (0.40) POLBAPEX1HTTTDP1PPARG
SCHEMBL22459328 0.89 S1PR1 (0.41) POLBAPEX1HTTTDP1PPARG
SCHEMBL22459221 0.88 TDP1 (0.36) POLBAPEX1HTTTDP1CYP11B1
SCHEMBL22459332 0.88 PPARD (0.39) CYP11B1CYP11B2MAPK1KDM4EMAPT
SCHEMBL22459701 0.87 POLB (0.50) POLBAPEX1HTTTDP1PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3725764-A1 POLYMERIZABLE COMPOUND HAVING METHOXYMETHYL ACRYLIC GROUP, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE JNC Corporation (JP) 2020-10-21 — — EP disclosed
US-20200299578-A1 POLYMERIZABLE COMPOUND HAVING METHOXYMETHYL ACRYLIC GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2020-09-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200299578-A1 POLYMERIZABLE COMPOUND HAVING METHOXYMETHYL ACRYLIC GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE SP1, CCND1, CPNE4 POLB 3467/4885APEX1 1393/4885HTT 4603/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback